| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62135-563-90 | 62135-563 | HUMAN PRESCRIPTION DRUG | Doxepin Hydrochloride | Doxepin Hydrochloride | CAPSULE | ORAL | 20221122 | N/A | ANDA | ANDA210268 | Chartwell RX, LLC | DOXEPIN HYDROCHLORIDE | 75 mg/1 | 90 CAPSULE in 1 BOTTLE (62135-563-90) |
| 62135-564-90 | 62135-564 | HUMAN PRESCRIPTION DRUG | Doxepin Hydrochloride | Doxepin Hydrochloride | CAPSULE | ORAL | 20221122 | N/A | ANDA | ANDA210268 | Chartwell RX, LLC | DOXEPIN HYDROCHLORIDE | 100 mg/1 | 90 CAPSULE in 1 BOTTLE (62135-564-90) |
| 62135-562-90 | 62135-562 | HUMAN PRESCRIPTION DRUG | Doxepin Hydrochloride | Doxepin Hydrochloride | CAPSULE | ORAL | 20221122 | N/A | ANDA | ANDA210268 | Chartwell RX, LLC | DOXEPIN HYDROCHLORIDE | 50 mg/1 | 90 CAPSULE in 1 BOTTLE (62135-562-90) |
| 62135-561-90 | 62135-561 | HUMAN PRESCRIPTION DRUG | Doxepin Hydrochloride | Doxepin Hydrochloride | CAPSULE | ORAL | 20221122 | N/A | ANDA | ANDA210268 | Chartwell RX, LLC | DOXEPIN HYDROCHLORIDE | 25 mg/1 | 90 CAPSULE in 1 BOTTLE (62135-561-90) |
| 62135-560-90 | 62135-560 | HUMAN PRESCRIPTION DRUG | Doxepin Hydrochloride | Doxepin Hydrochloride | CAPSULE | ORAL | 20221122 | N/A | ANDA | ANDA210268 | Chartwell RX, LLC | DOXEPIN HYDROCHLORIDE | 10 mg/1 | 90 CAPSULE in 1 BOTTLE (62135-560-90) |